Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study

Further Publications

Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2

JAMA Ophthalmol

von der Emde L, Hou J, Mukherjee S, Vance E, Agrón E, Domalpally A, Keenan TDL, AREDS2 Research Group

doi: 10.1001/jamaophthalmol.2025.3979

Further Publications

Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure

JAMA Ophthalmol

Hou J, von der Emde L, Mukherjee S, Vance E, Agrón E, Domalpally A, Chew EY, Keenan TDL, AREDS2 Research Group

doi: 10.1001/jamaophthalmol.2025.6002

Dry Eye Disease

Defining Discordance between Signs and Symptoms in Dry Eye Disease: Insights from the DRy Eye Assessment and Management (DREAM) Study

Am J Ophthalmol

Matar K, Yu Y, Augello P, Ying GS, Asbell PA, Sayegh RR, DREAM Research Group

doi: 10.1016/j.ajo.2026.02.031

Further Publications

Patient-Reported Importance of Functional Benefit in Geographic Atrophy

JAMA Ophthalmol

Dinah C, Enoch J, Ghulakhszian A, Sekhon M, Salvatore S, DeSalvo G, Kumar P, Banerjee S, Nayak D, Amoaku W, Shiew M, Osoba O, Crabb DP, Taylor DJ

doi: 10.1001/jamaophthalmol.2025.3264

Glaucoma and Ocular Pressure

Baseline risk factors for the development of open-angle glaucoma in a 12-year glaucoma incidence study: the Thessaloniki Eye Study

Br J Ophthalmol

Ntonti P, Coleman AL, Wilson MR, Harris A, Papakonstantinou E, Giannoulis DA, Kilintzis V, Haidich AB, Yu F, Pappas T, Anastasopoulos E, Vagiakis I, Raptou A, Tzoanou G, Topouzis F

doi: 10.1136/bjo-2025-328564

Macular Diseases

Changes of the Optic Nerve Head and Macula in High Myopia in a 10-Year Follow-Up: The Beijing Eye Study

Invest Ophthalmol Vis Sci

Jonas JB, Panda-Jonas S, Xu J, Jonas RA, Wang YX

doi: 10.1167/iovs.66.15.39

Glaucoma and Ocular Pressure

Intraocular Pressure Measurement Variability in the Ocular Hypertension Treatment Study

Ophthalmol Glaucoma

Shukla AG, Leshno A, De Moraes CG, Kass M, Gordon M, Tsamis E, Cioffi GA, Liebmann JM

doi: 10.1016/j.ogla.2026.06.004

Macular Diseases

Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial

Prog Retin Eye Res

Dinah C, Esmaeelpour M, Rachitskaya AV, De Salvo G, Munk MR

doi: 10.1016/j.preteyeres.2025.101421

Macular Diseases

Monitoring of Geographic Atrophy Progression in Age-Related Macular Degeneration Using Fluorescence Lifetime Imaging Ophthalmoscopy

Invest Ophthalmol Vis Sci

Sagurski N, Jaggi D, Lincke JB, Wolf S, Zinkernagel MS, Dysli C

doi: 10.1167/iovs.67.6.31

Related content

Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2

Proposal, Derivation, and External Validation of a Novel Geographic Atrophy Outcome Measure

Defining Discordance between Signs and Symptoms in Dry Eye Disease: Insights from the DRy Eye Assessment and Management (DREAM) Study

Patient-Reported Importance of Functional Benefit in Geographic Atrophy

Baseline risk factors for the development of open-angle glaucoma in a 12-year glaucoma incidence study: the Thessaloniki Eye Study

Changes of the Optic Nerve Head and Macula in High Myopia in a 10-Year Follow-Up: The Beijing Eye Study

Intraocular Pressure Measurement Variability in the Ocular Hypertension Treatment Study

Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial

Monitoring of Geographic Atrophy Progression in Age-Related Macular Degeneration Using Fluorescence Lifetime Imaging Ophthalmoscopy